Mitochondrial alterations in Alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 19, Issue 2, 2004, Pages 89-93

  Baloyannis, Stavros J ^a   Costa, Vassiliki ^a   Michmizos, Demetrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alzheimer's disease; Mitochondria; Ultra structure

Indexed keywords

AMYLOID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUDITORY CORTEX; CELL ULTRASTRUCTURE; CEREBELLUM; CLINICAL ARTICLE; CYTOPATHOLOGY; CYTOSKELETON; DEGENERATIVE DISEASE; DENDRITIC SPINE; ELECTRON MICROSCOPY; ENERGY METABOLISM; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LOCUS CERULEUS; MALE; METABOLIC DISORDER; MITOCHONDRION; MORPHOLOGY; MORPHOMETRICS; NERVE CELL; NEUROPATHOLOGY; OXIDATIVE STRESS; RED NUCLEUS; THALAMUS;

EID: 1942455459     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750401900205     Document Type: Article

References (29)

1. Terry RD: The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J Neuropathol Exp Neurol. 1996; 55(10): 1023-1025.
2. Baloyannis S, Manolidis S, Manolidis L: The acoustic cortex in Alzheimer's disease. Acta Otolaryngol Suppl. 1992; 494: 1-13.
3. Cras P, Kawai M, Siedlak S, et al.: Neuronal and microglial involvement in β-amyloid protein deposition in Alzheimer's disease. Am J Pathol. 1990; 37(2): 241-246.
4. Wisniewski HM, Wegiel J, Kotula L: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol. 1996; 22(1): 3-11.
5. Trimmer PA, Swerdlow RH, Parks JK, et al.: Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol. 2000; 162(1): 37-50.
6. Baloyannis SJ: Oxidative stress and mitochondria alterations in Alzheimer's disease. Neurobiol Aging. 2000; 21: 264.
7. Lynch T, Cherny R, Bush A: Oxidative processes in Alzheimer's disease: The role of abeta-metal interactions. Exp Gerontol. 2000; 35(4): 445-451.
8. Hirai K, Aliev G, Nunomura A, et al.: Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001; 21(9): 3017-3023.
9. Hirokawa N: Cross-linker system between neurofilaments, microtubules, and membraneous organelles in frog axons revealed by the quick freeze, deep etching method. J Cell Biol. 1982; 94(2); 355-382.
10. Wagner O, Lifshitz J, Janmey P, et al.: Mechanisms of mitochondria-neurofilament interactions. J Neurosci. 2003; 23(27): 9046-9058.
11. Beal MF, Hyman BT, Koroshetz W: Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 1993; 16(4): 125-131.
12. Baloyannis SJ: Mitochondrial alterations in Alzheimer's Disease. Neurobiol Aging. 1998; 19: S241.
13. Baloyannis SJ: The climbing fibres of the cerebellar cortex in Alzheimer's disease: A Golgi and electron microscope study. Brain Pathol. 1997; 7: 1203.
14. Baloyannis S: The Golgi apparatus of Purkinje cells in Alzheimer's disease. In Jurgen Bohl (ed.): Neuropathology-Back to the roots. Aachen: Shaker Vertag, 2002, 1-10.
15. Folstein M, Folstein S, McHugh P: "Mini-mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189-198.
16. Mattis S: Dementia Rating Scale Professional manual. Odessa: Psychological Assessment Resources, 1988.
17. Baloyannis SJ: Mitochondrial alterations in neurons of various areas of the brain in Parkinson's disease: An electron microscopy study. Parkinsonism Relat Disord. 2001; 7: S10.
18. Menzies FM, Cookson MR, Taylor RW, et al.: Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain. 2002; 125(Pt 7): 1522-1533.
19. Perry G, Nunomura A, Hirai K, et al.: Oxidative damage in Alzheimer's disease: The metabolic dimension. Int J Dev Neurosci. 2000; 18(4-5): 417-421.
20. Aliev G, Smith M, Seyidov D, et al.: The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathology. 2002; 12(1): 21-35.
21. Nunomura A, Perry G, Aliev G, et al.: Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001; 60(8): 759-767.
22. Bereiter-Hahn J, Voth M: Dynamics of mitochondria in living cells: Shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech. 1994; 27(3): 198-219.
23. Krendel M, Sgourdas G, Bonder EM: Disassembly of actin filaments leads to increased rate and frequency of mitochondria movements along microtubules. Cell Motile Cytoskeleton. 1998; 40(4): 368-378.
24. Leterrier JF, Rusakov DA, Nelson BD: Interactions between brain mitochondria and cytoskeleton: Evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Techn. 1994; 27(3): 233-261.
25. Kim SH, Vlkolinsky R, Cairns N, et al.: The reduction of NADH ubiquinone oxidoreductase 24- and 75k-kDa subunits in brain of patients with Down syndrome and Alzheimer's disease. Life Sci. 2001; 68(24): 2741-2750.
26. Blass JP, Sheu RK, Gibson GE: Inherent abnormalities in energy metabolism in Alzheimer disease: Interaction with cerebrovascular compromise. Ann N Y Acad Sci. 2000; 903: 204-221.
27. Anandatheerthavarada HK, Biswas G, Robin MA, et al.: Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003; 161(3): 41-54.
28. Mesulam M: Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol. 1990; 28(5): 597-613.
29. Kashiwaya Y, Tseshima T, Mori N, et al.: D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA. 2000; 97(10): 5440-5444.